Clinical Trials on Respiratory Syncytial Virus Hospitalizations

Total 10967 results

Pfizer

Completed

A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Infections

United Kingdom
Janssen Sciences Ireland UC

Terminated

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

Virus Diseases | Respiratory Syncytial Virus Infections

Australia, Spain, Belgium, Sweden, Netherlands, Brazil, Germany, Argentina, Philippines, United States
National Institute of Allergy and Infectious Diseases...

Completed

RSV Disease in the Elderly

Respiratory Syncytial Virus | Respiratory Infections, Acute

United States
National Institute of Allergy and Infectious Diseases...

Completed

RSV Challenge in Healthy Adults

Respiratory Syncytial Virus | Respiratory Infections, Acute

United States
Tatyana Zubkova

Completed

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Respiratory Syncytial Virus Infections

Russian Federation
Zhuhai Trinomab Pharmaceutical Co., Ltd.

Completed

A Study of TNM001 in Chinese Healthy Preterm and Term Infants

Respiratory Syncytial Virus Infections

China
Kexing Biopharm Co., Ltd.

Recruiting

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

Respiratory Syncytial Virus Infections

China
ModernaTX, Inc.

Active, not recruiting

A Study of Modified mRNA Vaccines in Healthy Adults

Cytomegalovirus | SARS-CoV-2 | Seasonal Influenza | Respiratory Syncytial Virus

United States
Zhuhai Trinomab Pharmaceutical Co., Ltd.

Not yet recruiting

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

Respiratory Syncytial Virus Infections

China
Uppsala University
Swedish University of Agricultural Sciences

Completed

Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus (IMAR)

Respiratory Tract Infections | Respiratory Syncytial Virus Infections

Sweden
MedImmune LLC

Completed

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. (MEDI8897 Ph2b)

Respiratory Syncytial Virus Infections

United States, Canada, Finland, France, Italy, Spain, Belgium, Hungary, Turkey, United Kingdom, New Zealand, Brazil, South Africa, Australia, Bulgaria, Czechia, Poland, Estonia, Lithuania, Chile, Latvia, Sweden, Argentina
Sunnybrook Health Sciences Centre
Abbott

Completed

Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

Respiratory Syncytial Virus Infections | Lower Respiratory Tract Infection

Canada
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Influenza, Human Prevention | Respiratory Syncytial Viruses Prevention

United States
Rigshospitalet, Denmark

Recruiting

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

COVID-19 | Influenza | RSV Infection

Denmark
AstraZeneca

Completed

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY) (MELODY)

Respiratory Syncytial Virus Infections

United States, Finland, Spain, Belgium, France, Korea, Republic of, Turkey, Austria, New Zealand, South Africa, Australia, Germany, Bulgaria, United Kingdom, Ukraine, Argentina, Czechia, Panama, Estonia, Lithuania, Poland, Japan, Co... and more
University Hospital of Patras

Recruiting

Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients (INTERACT)

Covid19 | Hospitalization

Greece
Tongji Hospital

Enrolling by invitation

Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in Central China, Wuhan

RSV Infection

China
Pfizer

Completed

A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants

Respiratory Syncytial Viruses

Belgium
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Recruiting

A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model

RSV Infection

United Kingdom
Ankara University

Completed

Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial) (TurkNICU-RSV)

Respiratory Syncytial Virus Infections | Infections, Epidemics

Turkey
Janssen Research & Development, LLC

Terminated

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus Infections

United States, Taiwan, Belgium, Hungary, Thailand, United Kingdom, Germany, Korea, Republic of, Bulgaria, Turkey, France, Italy, Poland, Spain, Brazil, Russian Federation, Japan, Argentina, Malaysia, Mexico, Sweden, South Africa
GlaxoSmithKline

Completed

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

Respiratory Syncytial Virus Infections

United States, Belgium, Canada
Evandro Chagas National Institute of Infectious...
Federal University of Minas Gerais; Universidade Federal de Santa Maria; Universidade... and other collaborators

Unknown

Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL (Recoversus)

Covid19 | Hospitalization

Brazil
University of Oxford

Active, not recruiting

RESCEU: Defining the Burden of RSV Disease

Respiratory Syncytial Virus Infections | RSV Infection

United Kingdom
Janssen Research & Development, LLC

Completed

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus Infections

Japan
MedImmune LLC

Completed

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age (CP149)

Respiratory Syncytial Virus Infections | Respiratory Viral Infections | Parainfluenza Virus 3, Human

United States
Pulmocide Ltd

Terminated

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients (TreatRSV1)

Respiratory Syncytial Virus Infections

United Kingdom
AbbVie

Completed

A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus (Synagis Russia)

Respiratory Syncytial Virus (RSV)
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age

Respiratory Syncytial Virus Infections

United States
Novavax

Completed

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

Respiratory Syncytial Viruses

Australia
Janssen Pharmaceutica N.V., Belgium

Completed

Idylla IFV-RSV Panel Clinical Testing (RP1)

Respiratory Tract Infections | Influenza, Human | Respiratory Syncytial Virus Infections

United States
Pfizer

Recruiting

A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants (MORISOT)

Respiratory Syncytial Virus

South Africa
Fadoi Foundation, Italy

Completed

Observational Study in COVID-19 Patients Treated With Remdesivir (RECOVER)

Hospitalization

Italy
University Hospital, Antwerp
Philips Respironics

Terminated

Cough Assist in Bronchiolitis

Bronchiolitis | Respiratory Syncytial Virus

Belgium
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Respiratory Syncytial Virus | Respiratory Tract Infection

United States, Chile, Colombia, Korea, Republic of, South Africa, Spain
Kırıkkale University

Enrolling by invitation

Evaluation of Lung Ultrasonography Findings in Newborns With Respiratory Syncytial Virus Bronchiolitis

Bronchiolitis | RSV Infection

Turkey
University Hospital, Rouen

Completed

TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit

Influenza | Respiratory Syncytial Viruses

France
Ablynx

Completed

Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection (Respire)

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Belgium, Hungary, Israel, Spain, Estonia, Philippines, Thailand, Bulgaria, Poland, Germany, Chile, Colombia, Croatia, Czechia, Latvia, Malaysia, Slovakia
Ablynx

Terminated

Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Japan
Sanofi Pasteur, a Sanofi Company
AstraZeneca

Active, not recruiting

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life (VAS00006)

Healthy Volunteer | RSV Immunization

France, Germany, United Kingdom
Winthrop University Hospital

Completed

Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study

Bronchiolitis | RSV Infection

United States
MedImmune LLC

Completed

Study to Evaluate MEDI-534 in Healthy Adults

Respiratory Syncytial Virus Infections | Parainfluenza Infections

United States
Centre Hospitalier Universitaire Dijon

Completed

Perceived Health After Hospitalization for COVID-19 (PRO-COVID)

COVID-19, Post-hospitalization, Disease Impact

France
Ablynx

Withdrawn

Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Belgium, Spain, Australia
Hospital of South West Jutland

Completed

Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.

Respiratory Syncytial Virus Bronchiolitis

Denmark
Hamad Medical Corporation

Completed

"Palivizumab Therapy for RSV-bronchiolitis"

Respiratory Syncytial Virus-bronchiolitis

Qatar
University Hospitals, Leicester
Pediatric Emergency Research in the UK and Ireland (PERUKI); Respiratory syncytial...

Recruiting

COVID-19 Impact on RSV Emergency Presentations (BronchSTART)

Bronchiolitis; Respiratory Syncytial Virus

United Kingdom
GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

Respiratory Syncytial Virus Infections

Netherlands, Spain, Belgium, United States
MedImmune LLC

Completed

Respiratory Events Among Premature Infants

Respiratory Syncytial Virus

United States
University Hospital, Akershus
University of Oslo

Recruiting

Antibiotic Therapy in Viral Airway Infections (ATHENIAN)

Respiratory Tract Infections | Infectious Disease | Influenza | Respiratory Syncytial Virus (RSV)

Norway

Clinical Trials on Respiratory Syncytial Virus Hospitalizations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations